BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) 

Av. Mare de Déu de Montserrat, 221

Barcelona      Spain
Phone: 34-93-446-60-00 Fax: 34-93-433-00-72


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) And U.A.B. Advances In Their Program To Develop A Cure For Sanfilippo A Syndrome 3/11/2014 10:08:41 AM
REGENX Biosciences, LLC And Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Enter Into License Agreement For Development Of Treatments For Serious, Rare Lysosomal Storage Disorder Using NAV® rAAV9 Vectors 3/10/2014 10:12:48 AM
Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Announces Positive Results From Its Phase 2 Clinical Study of E-58425 in Acute Pain 10/16/2013 6:59:14 AM
Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Announces Publication of Key Preclinical Data for a Novel Oral, First-in-class New Chemical Entity (NCE) Sigma-1 Receptor Antagonist (E-52862), that has Completed Phase I and Initiated its Phase II Clinical Trial Program 7/17/2012 9:56:12 AM
Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Opens Second Factory in China 10/28/2010 1:19:07 PM
Recordati S.p.A Signs Co-Marketing Agreement With Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) In Spain For Pitavastatin 4/7/2010 10:34:48 AM
Esteve S.A. (Laboratorios Del Dr. Esteve S.A.): Innate Immune Mechanisms Can Control Disease Progression In HIV-Positive Patients 2/26/2010 1:33:29 PM
Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) And IRSICAIXA Sign Partnership Agreement For The Development Of A Vaccine Against AIDS 1/9/2009 12:11:20 PM
Wex Pharmaceuticals Inc. (WXIFF.PK) and Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Terminate Collaboration on Tetrodotoxin 5/14/2007 1:58:57 PM
Wex Pharmaceuticals Inc. (WXIFF.PK) Receives EUR 2,000,000 From Co-Development Partner10/19/2005 5:13:14 PM
12